Global Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services 2017

2017-10-03

“Clinical Laboratory, Cardiac, Molecular Diagnostics and Genomic Testing Services. Strategies & Trends. Volume & Price Forecasts by Laboratory Department 2017 to 2022 – Global Version” provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

changing demographics emerging economies and global prosperity biotechnology advances in genetics healthcare expansion in China climate change globalization automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

Key Topics Covered:

1. Introduction and Market Definition 1.1 The Growing Demand for Clinical Testing 1.2 Defining the Opportunity 1.2.1 Volumes1.2.2 Prices 1.2.3 Revenue Market Size1.3 Methods and Sources 1.3.1 Authors 1.3.2 Sources 1.4 U.S. Medical Market and Clinical Laboratory Testing – Perspective 1.3.1 U.S. Medicare Expenditures for Clinical Testing

2. Overview of a Dynamic Market 2.1 Market Players – Roles & Impacts 2.1.1 Supplier/pharmaceutical 2.1.2 Independent lab specialized/esoteric 2.1.3 Independent lab national/regional 2.1.4 Independent lab analytical 2.1.5 Public National/regional lab 2.1.6 Hospital lab2.1.7 Physician lab2.1.8 Audit body 2.2 Segmentation – Different Approaches 2.2.1 Traditional Market Segmentation 2.2.2 Laboratory Focus and Segmentation 2.3 Structure of Clinical Testing Industry 2.3.1 The Hospital Lab – Share of the Pie2.3.2 Key Role for Economies of Scale 2.3.3 Physician Office Lab’s are Still Here 2.3.4 Physician’s and POCT – Reviving Patient Service in China 2.4 Profiles of Key Companies 2.4.1 Quest Diagnostics 2.4.2 Laboratory Corporation of America 2.4.3 Lifelabs Medical Laboratory Services 2.4.4 ACM Medical Laboratory 2.4.5 Spectra Laboratories, Inc. 2.4.6 Bio-Reference Laboratories, Inc. 2.4.7 CompuNet Clinical Laboratories, LLC 2.4.8 Genzyme Corporation 2.4.9 Sonic Healthcare Limited 2.4.10 Exagen Diagnostics, Inc. 2.4.11 Clongen Laboratories LLC 2.4.12 Clinical Reference Laboratory, Inc. 2.4.13 Mid America Clinical Laboratories, LLC 2.4.14 Miraca Life Sciences, Inc. 2.4.15 Psychemedics Corp. 2.4.16 Aurora Diagnostics, LLC 2.4.17 DL Reference Laboratory 2.4.18 Myriad Genetics, Inc. 2.4.19 Bioscientia Institut fuer Medizinische Diagnostik GmbH 2.4.20 Acibadem Labmed Laboratory 2.4.21 Eurofins Scientific 2.4.22 The Doctor’s Laboratory (Sonic Healthcare U.K.) 2.4.23 Pathology Inc. 2.4.24 Gribbles Pathology 2.4.25 B.P. CLINICAL LAB 2.4.26 Diagnsticos da Amrica (DASA) 2.4.27 American Bio-Clinical Laboratories, Int’l 2.4.28 Adicon Clinical Laboratories 2.4.29 Dian Diagnostics 2.4.30 Kingmed Diagnostics 2.4.31 Ascend Clinical, LLC 2.4.32 Unilabs SA 2.4.33 American Pathology Partners, Inc. 2.4.34 Integrated Regional Laboratories, Inc. 2.4.35 Viracor Laboratories2.4.36 Neogenomics 2.4.37 Genomic Health, Inc. 2.4.38 ARUP Laboratories, Inc. 2.4.39 Enzo Biochem, Inc. 2.5 National and Regional Diversity

3. Trends Driving a Changing Market 3.1 Growth Is Pushed From Many Sides 3.1.1 Understanding the Impact of Aging Population. 3.1.2 Economic growth a Key Driver3.1.3 Point of Care Testing can increase demand 3.1.4 Alternative Medicine Creates Testing Opportunity 3.1.5 Esoteric Testing Moving Mainstream 3.1.6 Genetic Based Testing Creates New Department and New Discipline3.2 Factors At Work To Shrink The Market 3.2.1 Lower costs trend to continue 3.2.2 Economic or population contraction. 3.2.3 Testing usage analysis curtailing growth. 3.2.4 Wellness has a downside 3.2.5 Test Displacement Impacts Important 3.2.6 Point of Care Testing 3.3 Automation 3.3.1 Stranded LIMS Investment 3.3.2 Software as a Service 3.3.3 Physician Office and Access Systems 3.4 Environment and Evolution 3.5 Diagnostic Technology Development 3.5.1 Next Generation Sequencing Fuels a Revolution3.5.2 Impact of NGS on pricing 3.5.3 POCT/Self Testing Disruptive Force 3.5.4 Pharmacogenomics Blurs Diagnosis and Treatment 3.5.5 CGES Testing, A Brave New World3.5.6 Molecular Diagnostics Technologies At The Forefront of Growth 3.5.7 Biochips/Giant magneto resistance based assay

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 4.1 Recent Developments – Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section 4.2 LabCorp explores acquisition of clinical trials firm PPD 4.3 Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies 4.4 PSP to acquire European medical lab services company 4.5 Mars, Incorporated to Acquire VCA Inc. 4.6 Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth 4.7 Takara Bio USA Holdings and Rubicon Genomics Announce Merger Agreement 4.8 Instrumentation Laboratory Acquires CA Casyso AG 4.9 Schryver Medical Completes Acquisitions of Professional Clinical Laboratory, Inc. 4.10 Grail, Illumina’s billion-dollar diagnostics startup 4.11 Grifols acquires Hologic’s blood screening unit for $1.85bn 4.12 Bio-Rad Laboratories to buy US firm RainDance Technologies 4.13 Abbott Laboratories to buy St. Jude Medical for $25 billion 4.14 CombiMatrix Gets Serious About Potential M&A Options in Wake of $8M Offering 4.15 Abbott to Acquire Alere, Becoming Leader in Point of Care Testing 4.16 Achieving Dx Ambitions Key to Avant-Amarantus-Theranostics Merger 4.17 LabCorp Agrees to Acquire Assets of Pathology Inc. 4.18 NeoGenomics Completes Acquisition of Clarient, Inc. 4.19 FDA Gets Pushback on Move to Regulate Lab Developed Tests 4.20 Cancer Genetics, Inc. Announces Partnership 4.21 Theranos plans to close all its clinical labs 4.22 Forte Capital Lowers stake in Laboratory Corp. 4.23 US Oncology Network Selects Myriad Genetics 4.24 Pyxant Labs Commences Clinical Laboratory Testing Services 4.25 Viewics Launches Diabetes Management 4.26 Alpha Genomix And Rx30 Partner4.27 LabCorp Doubles Testing Capacity Of Covance 4.28 LabCorp to acquire clinical laboratories from Mount Sinai 4.29 PerkinElmer to buy Germany’s Euroimmun for about $1.3 billion 4.30 LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash 4.31 Precipio Diagnostics and Transgenomic Complete Merger 4.32 $550 Dock Turns a Smartphone into a Medical Lab 4.33 LabCorp & Interpace Extend Deal, Boost Cancer Portfolio

5. Country Market Sizes – North America 2014 to 2022

6. Country Markets – Europe 2014 to 2022

7. Country Markets – Asia Pacific 2014 to 2022

8. Country Markets – Latin America, Africa & The Middle East 2014 to 2022

9. Global Market Summary 2014 to 20229.1 Global Market 2014 to 2022 9.1.1 Clinical Chemistry – Volumes, Prices, Revenues 9.1.2 Microbiology – Volumes, Prices, Revenues 9.1.3 Hematology – Volumes, Prices, Revenues 9.1.4 Anatomic Pathology – Volumes, Prices, Revenues 9.1.5 Molecular Diagnostics – Volumes, Prices, Revenues 9.1.6 All Clinical Testing – Volumes, Prices, Revenues 9.1.7 Cardiac Biomarkers – Volumes, Prices, Revenues 9.1.8 Molecular Diagnostic Oncology – Volumes, Prices, Revenues 9.1.9 Molecular Diagnostic Genetics – Volumes, Prices, Revenues

10. The Future of the Clinical Laboratory

For more information about this report visit https://www.researchandmarkets.com/research/pwpv7s/clinical

Media Contact:

Laura Wood, Senior Manager [email protected]  

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-clinical-laboratory-cardiac-molecular-diagnostics-and-genomic-testing-services-2017-300529773.html

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Information contained on this page is provided by an independent third-party content provider. This Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact support [at] perpetualwire.com.

Live Traffic in Charlotte, NC